Patheon has launched the SoluPath Flex™, providing the pharmaceutical industry with a new low solubility solution.

This new offering allows customers to select from a full array of technologies and services to tailor a unique solution designed for each individual need, timeline and budget.

With SoluPath Flex a wide-ranging list of solubility solutions can be completed in a single lab. And as the molecule progresses, the Patheon network then allows for a seamless transition to clinical trial and commercial supply, which saves time in development for the customers.

Patheon global head of formulation sciences Anil Kane said: "SoluPath Flex allows our customers to partner with our scientific experts to determine the most effective and strategic ways to solve and overcome early development challenges related to solubility.

"SoluPath Flex gives customers a simplified and customizable solution and the opportunity to work directly with a solubility expert from Patheon to define a solution to meet each unique requirement. All projects will be initiated and completed by a dedicated team working in a non-GMP lab within a GMP facility."